Product Information
AZELASTINE HCL 0.05% DROPS is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.0124 per ML under NDC 62332050606. Its NADAC has been published 363 times since Oct 23, 2019.
FDA first approved this application on Mar 20, 2019. Its Orange Book therapeutic-equivalence code is AT.
Strength
.5 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332050606
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
AZELASTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209620FDA Approved
3/20/2019
TE Code
AT
On Market Since
3/20/2019
Pharmacological Classes
Price Statistics
The NADAC for AZELASTINE HCL 0.05% DROPS has been published 363 times since Oct 23, 2019, and over the history we have for it it has declined 31.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0124 per ML |
|---|---|
| All-time high | $1.6853 (Jul 15, 2020) |
| All-time low | $0.8789 (Apr 22, 2026) |
| 52-week high | $1.0124 |
| 52-week low | $0.8789 |
| Median price | $1.1288 |
| Average price | $1.1849 |
| Largest weekly change | +55.0% (Nov 22, 2023) |
| Weeks tracked | 363 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Azelastine Hydrochloride Ophthalmic Solution 0.05% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Azelastine Hydrochloride Ophthalmic Solution 0.05% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZELASTINE HCL 0.05% DROPS?
The current National Average Drug Acquisition Cost (NADAC) for AZELASTINE HCL 0.05% DROPS, manufactured by Alembic Pharmaceuticals Inc., is $1.0124 per ML (NDC 62332050606), effective Sep 30, 2026.
How has the price of AZELASTINE HCL 0.05% DROPS changed over time?
Over the history we have for it, the NADAC for AZELASTINE HCL 0.05% DROPS has declined 31.1%. It has been tracked across 363 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for AZELASTINE HCL 0.05% DROPS?
Since Oct 23, 2019, the NADAC for AZELASTINE HCL 0.05% DROPS has ranged from a low of $0.8789 (Apr 22, 2026) to a high of $1.6853 (Jul 15, 2020), with a median of $1.1288 per ML.
Are there cheaper alternatives to AZELASTINE HCL 0.05% DROPS?
No other NADAC-published product currently shares the active ingredient and strength of AZELASTINE HCL 0.05% DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZELASTINE HCL 0.05% DROPS?
AZELASTINE HCL 0.05% DROPS (NDC 62332050606) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.